Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | ATPase family, AAA domain containing 5 | Starlite/ChEMBL | No references |
Mus musculus | RAR-related orphan receptor gamma | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Echinococcus multilocularis | atpase aaa+ type core atpase aaa type core | Get druggable targets OG5_139225 | All targets in OG5_139225 |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium leprae | Conserved hypothetical protein | 0.0365 | 0.3651 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0012 | 0 | 0.5 |
Giardia lamblia | Transglutaminase/protease, putative | 0.0365 | 0.3651 | 0.5 |
Mycobacterium leprae | Conserved hypothetical protein | 0.0365 | 0.3651 | 0.5 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.0365 | 0.3651 | 0.5 |
Mycobacterium tuberculosis | Long conserved protein | 0.0365 | 0.3651 | 0.5 |
Onchocerca volvulus | 0.0365 | 0.3651 | 1 | |
Mycobacterium ulcerans | hypothetical protein | 0.0365 | 0.3651 | 0.5 |
Mycobacterium ulcerans | hypothetical protein | 0.0365 | 0.3651 | 0.5 |
Mycobacterium ulcerans | transglutaminase family protein | 0.0365 | 0.3651 | 0.5 |
Loa Loa (eye worm) | steroid hormone receptor | 0.0012 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0012 | 0 | 0.5 |
Loa Loa (eye worm) | nuclear hormone receptor family member nhr-41 | 0.0012 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0012 | 0 | 0.5 |
Loa Loa (eye worm) | nuclear hormone receptor family member nhr-40 | 0.0012 | 0 | 0.5 |
Loa Loa (eye worm) | nuclear hormone receptor family member nhr-14 | 0.0012 | 0 | 0.5 |
Mycobacterium tuberculosis | Hypothetical protein | 0.0365 | 0.3651 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0012 | 0 | 0.5 |
Giardia lamblia | Hypothetical protein | 0.0365 | 0.3651 | 0.5 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.0365 | 0.3651 | 0.5 |
Mycobacterium ulcerans | putative transglutaminase-like protein | 0.0365 | 0.3651 | 0.5 |
Mycobacterium tuberculosis | Conserved protein | 0.0365 | 0.3651 | 0.5 |
Trichomonas vaginalis | peptide N-glycanase, putative | 0.0365 | 0.3651 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0012 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0012 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0012 | 0 | 0.5 |
Loa Loa (eye worm) | nuclear hormone receptor family member nhr-1 | 0.0012 | 0 | 0.5 |
Loa Loa (eye worm) | nuclear hormone receptor family member nhr-31 | 0.0012 | 0 | 0.5 |
Echinococcus granulosus | Transglutaminase | 0.0365 | 0.3651 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0365 | 0.3651 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0012 | 0 | 0.5 |
Loa Loa (eye worm) | nuclear hormone receptor family member nhr-49 | 0.0012 | 0 | 0.5 |
Brugia malayi | Thioredoxin family protein | 0.0365 | 0.3651 | 1 |
Loa Loa (eye worm) | nuclear Hormone Receptor family member | 0.0012 | 0 | 0.5 |
Echinococcus multilocularis | Transglutaminase | 0.0365 | 0.3651 | 0.3651 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | = 12.5893 um | PUBCHEM_BIOASSAY: VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 18.3489 uM | PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125] | ChEMBL. | No reference |
Potency (functional) | = 35.4813 um | PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.